Fall River Charter School Enters First of its Kind Partnership with MIT BLOSSOMS
Mar 30, 2017 11:45 am UTC| Business
CAMBRIDGE, Mass., March 30, 2017 -- The Massachusetts Institute of Technology (MIT) BLOSSOMS Program (Blended Learning Open Source Science Or Math Studies) today announced it has signed a first-of-its-kind partnership...
Affimed Reports Financial Results for Fourth Quarter and Year End 2016
Mar 30, 2017 11:31 am UTC| Business
Heidelberg, Germany, March 30, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial results...
Amerigo Announces Filing of NI 43-101 Technical Report
Mar 30, 2017 11:30 am UTC| Business
VANCOUVER, British Columbia, March 30, 2017 -- Amerigo Resources Ltd. (TSX:ARG) ("Amerigo" or the "Company") is pleased to announce that it has filed a technical report (the "Report") prepared for Minera Valle Central,...
Agios to Present at the 16th Annual Needham Healthcare Conference on Tuesday April 4, 2017
Mar 30, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass., March 30, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the company is scheduled to present...
Mar 30, 2017 11:30 am UTC| Business
SAINT-GENIS-POUILLY, France, March 30, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced a 10-year...
Mar 30, 2017 11:25 am UTC| Business
Hollywood, March 30, 2017 -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development,...
Matinas BioPharma Appoints Eric J. Ende, M.B.A, M.D. to its Board of Directors
Mar 30, 2017 11:05 am UTC| Business
BEDMINSTER, N.J., March 30, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today...
US–India Trade Talks Race Toward USD 500 Billion Goal